Bioven_eng

Indications:

• replacement therapy – primary immunodeficiency syndromes such as: congenital agammaglobulinemia and hypogammaglobulinemia, common variable immunodeficiency, severe combined immunodeficiency, Wiskott Aldrich syndrome, transient hypogammaglobulinemia in children
• secondary immunodeficiency syndromes such as: severe recurrent bacterial infections in children with HIV/AIDS, cytopenia of different origin (acute and chronic leukemia, aplastic anemia, condition after cytostatic therapy), severe forms of bacterial-toxic and viral infections in adults and children (including surgical complications accompanied by bacteremia and septicopyemic conditions and in preparation of surgical patients to surgery), prophylaxis and treatment of infections in premature infants with low birth weight
• immunomodulation therapy: idiopathic thrombocytopenic purpura, Guillain Barré syndrome, Kawasaki syndrome, chronic inflammatory neuropathy (demyelinating), general myopathy, Wegener granulomatosis, dermatomyositis, systemic connective tissue diseases (rheumatoid arthritis)